NeuralInk

CA - FremontMedical Devices2 H-1B visas (FY2023)

View 81 open jobs Website LinkedIn Careers Page

Focus: NeuralInk is a medical device company specializing in neural implants for severe neurological conditions, headquartered in Fremont, CA. The company is developing brain-computer interface technology and assistive robotic systems targeting spinal cord injury and paralysis.

Unknown Robotics Neurosurgery Neuroscience

Profile data last refreshed 3h ago · AI intelligence enriched 1w ago

Open Jobs

81+2 this month

Stable — net +2 jobs in 30d

14 added, 12 removed. Backfill posture.

Should You Work at NeuralInk?

AI assessment

NeuralInk is a high-risk, high-reward early-stage medical device play best suited for career-builders willing to trade stability for equity upside and rare technical exposure in neural implants.

Why Work Here

Early-stage neural implant technology with rare therapeutic focus on tetraplegia/tetraparesis—joining now means ground-floor exposure to breakthrough BCI applications before market validation

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Eye Tracker

Spinal Cord Injury

N/A

Clinical Trials (1)

NCT07407725Clinical Outcome Assessment for AT & BCI

N/A

Help build intelligence for NeuralInk

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

81 active job openings signal aggressive hiring across hardware, software, and translational roles—significant opportunity for rapid advancement and skill-building in pre-commercialization phase

100% H1B approval rate (2 of 2 in 2023) and strong internship pipeline (19 roles) suggest stable sponsorship and mentorship culture for early-career professionals

Watch Out For

No revenue, pipeline stage data, or funding transparency available—makes it difficult to assess financial runway, Series funding risk, or acquisition likelihood
Minimal clinical presence (only 1 clinical role open; 7 trials with no published phase data) raises questions about regulatory readiness and clinical infrastructure maturity
Zero published peer-reviewed research on file suggests limited scientific validation or thought leadership in a space where publications drive hiring and partnerships

Generated by Claude from NeuralInk's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

N1 Implant

Tetraplegia/Tetraparesis

N/A

Clinical Trials (1)

NCT07127172GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

N/A

N1 Implant

Tetraplegia/Tetraparesis

N/A

Clinical Trials (1)

NCT07224256VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

N/A

N1 Implant

Tetraplegia/Tetraparesis

N/A

Clinical Trials (1)

NCT06700304CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

N/A

N1 Implant

Tetraplegia/Tetraparesis

N/A

Clinical Trials (1)

NCT06429735Precise Robotically IMplanted Brain-Computer InterfacE

N/A

N1 Implant

Tetraplegia/Tetraparesis

N/A

Clinical Trials (1)

NCT06992596UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

N/A

Assistive Robotic Arm

Tetraplegia/Tetraparesis

N/A

Clinical Trials (1)

NCT06710626Control of Assistive Devices Via Brain-Computer Interface Technology

N/A

Interview Prep Quick Facts

Portfolio: 7 clinical trials

Top TAs: Neurology

H-1B (2023): 2 approvals

Open Roles: 81 active jobs

Therapeutic Area Focus

Neurology

7 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-2

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

NeuralInk

Should You Work at NeuralInk?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Open Jobs (81)

Veterinary Technician

Mechanical Design Engineer

Software Engineer, Robot Manufacturing

Software Engineer, Pathology and Digital Imaging

Software Engineer, Hippocampus

Microfabrication Engineer (R&D)

Senior Accountant, Cost and Manufacturing Accounting

Network Engineer

Systems Engineer - Compute

Histopathology Intern

Rapid Prototyping Technician

Software Engineer, Medical Imaging

Pathology Specialist, Anatomic Pathology

Project Manager, Construction Management

Software Engineer - HIL

Software Engineer - Simulation

Robotics Engineer

IT Security & Identity Engineer

Security Engineer

Software Engineer Intern, BCI Applications

Physical Design and Verification Engineer

Manufacturing Material Coordinator

Infrastructure Engineer, Mechanical Tooling

Contracts Manager

EMC Compliance Engineer

Hiring Trend

Visa Sponsorship